Targeted theranostics of lung cancer: PD-L1-guided delivery of gold nanoprisms with chlorin e6 for enhanced imaging and photothermal/photodynamic therapy

Bin Liu,Guanglei Qiao,Yu Han,E Shen,Gabriel Alfranca,Haisong Tan,Lirui Wang,Shaojun Pan,Lijun Ma,Wujun Xiong,Yanlei Liu,Daxiang Cui
DOI: https://doi.org/10.1016/j.actbio.2020.09.040
IF: 10.633
2020-11-01
Acta Biomaterialia
Abstract:<p>Peptide modified nanoparticles have emerged as powerful tools for enhanced cancer diagnosis and novel treatment strategies. Here, human programmed death-ligand 1 (PD-L1) peptides were used for the first time for the modification of gold nanoprisms (GNPs) to enhance targeting efficiency. A multifunctional nanoprobe was developed that the /Ce6-PD-L1 peptide (/Ce6-P) was used for imaging-guided photothermal/ photodynamic therapy by using the targeting effect of PD-L1. Both confocal imaging and flow cytometry experiments demonstrated a remarkable affinity of the as-prepared nanoprobes /Ce6-P to lung cancer cells (HCC827), which have a high PD-L1 expression. Subsequent <em>in vitro</em> and <em>in vivo</em> experiments further demonstrated that the nanoprobes /Ce6-P not only allowed for real-time visualization via fluorescence (FL) imaging and photoacoustic (PA) imaging, but also served as phototherapy agents for synergistic photothermal therapy (PTT) and photodynamic therapy (PDT). Furthermore, treatments on human lung cancer cells-derived tumors demonstrated that the nanoprobes /Ce6-P could significantly suppress tumor growth through PTT and PDT from GNPs and Ce6, respectively. In conclusion, the as-prepared new nanoprobes show promising potential for nanomedicine with remarkable targeting ability for dual-mode imaging and enhanced PDT and PTT effects on lung cancer.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop a new type of multifunctional nanoprobe for the diagnosis and treatment of lung cancer. Specifically, the researchers designed a nanoprobe based on gold nan prisms (GNPs), which was modified by PD - L1 peptide to improve its targeting efficiency for lung cancer cells. This nanoprobe can be used not only for fluorescence imaging (FL) and photoacoustic imaging (PA), but also can achieve the synergistic effect of photothermal therapy (PTT) and photodynamic therapy (PDT) under near - infrared laser irradiation, thus effectively inhibiting tumor growth. ### Core problems of the paper 1. **Improving the targeting of lung cancer treatment**: - Use human programmed death ligand 1 (PD - L1) peptide to modify gold nan prisms to enhance the targeting ability for lung cancer cells. - Verify the affinity of the modified nanoprobe for lung cancer cells with high PD - L1 expression (such as HCC827 cells) in vitro and in vivo experiments. 2. **Multi - modal imaging and treatment**: - Develop a nanoprobe integrating fluorescence imaging and photoacoustic imaging functions for real - time tumor monitoring. - Utilize the photothermal and photodynamic properties of the nanoprobe to achieve efficient treatment of lung cancer. 3. **Verify the treatment effect**: - Evaluate the synergistic effect of the nanoprobe in photothermal therapy and photodynamic therapy through in vitro and in vivo experiments. - Study the effect of the nanoprobe in inhibiting the growth of tumors derived from lung cancer cells. ### Key technologies and methods - **Design and synthesis of nanoprobe**: - Synthesize gold nan prisms (GNPs) and perform surface modification with polyethylene glycol (PEG) and PD - L1 peptide. - Load the photosensitizer zinc chloride (Ce6) onto the nanoprobe to form the GNPs@PEG/Ce6 - P nanoprobe. - **Imaging technology**: - Fluorescence imaging (FL) and photoacoustic imaging (PA) are used to monitor the distribution and accumulation of the nanoprobe in cell and animal models. - **Treatment effect evaluation**: - The synergistic effect of photothermal therapy (PTT) and photodynamic therapy (PDT) is evaluated through laser irradiation experiments. - Cell viability detection (CCK - 8), cell apoptosis detection (Annexin V - FITC/PI) and histological analysis (TUNEL and H&E staining) are used to evaluate the treatment effect. ### Conclusion The research results show that the designed GNPs@PEG/Ce6 - P nanoprobe has significant targeting ability, can monitor tumors in real - time under multiple imaging modes, and effectively inhibits the growth of lung cancer cells under the synergistic effect of photothermal therapy and photodynamic therapy. This research provides new strategies and technical means for the precise diagnosis and treatment of lung cancer.